VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ISLB 2022 | Liquid biopsy for breast cancer

Nicola Fusco, MD, European Institute of Oncology (IEO), Milan, Italy, discusses the use of liquid biopsy for breast cancer. Tissue biopsy is a useful tool for breast cancer, however there are limitations in regards to heterogeneity and it can sometimes be difficult to get a comprehensive molecular picture of disease. Liquid biopsy is already being used in clinical practice for some patients with breast cancer and Dr Fusco discusses the possible future applications of this technique. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consulting/advisory role: Novartis, AstraZeneca, Diaceutics, Adicet Bio, Sermonix
Speaker bureau: MSD, Boehringer Ingelheim, Novartis, AstraZeneca, Daiichi Sankyo, GSK, Gilead, Diaceutics
Research grants: Novartis, Reply

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter